Myrian XP-Prostate option AI

Intrasense by Guerbet
Information source: Vendor
Last updated: June 6, 2024

General Information

General
Product name Myrian XP-Prostate option AI
Company Intrasense by Guerbet
Subspeciality Abdomen
Modality MR
Disease targeted Prostate cancer
Key-features Prostate segmentation, prostate volume, highlighted suspicious areas
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
After: diagnosis verification, Possible interaction with results

Technical Specifications

Data characteristics
Population Male adult
Input MRI, T2, DWI, DCE (optional)
Input format DICOM
Output Probability map, structured report with key images, volumes and risk score
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA No or not yet
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since 04-2024
Distribution channels Myrian
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription, One-time license fee
Based on Number of users, Number of installations

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers